Original Article
European Journal of Clinical Nutrition (2009) 63, 821–827; doi:10.1038/ejcn.2008.49; published online 5 November 2008
Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials
Z-h Wei1,2, H Wang1,2, X-y Chen1, B-s Wang1, Z-x Rong1, B-s Wang1, B-h Su1 and H-z Chen1
1Department of Pharmacology and Biostatistics, Institute of Medical Sciences, Shanghai Jiaotong University School of Medicine, Shanghai, China
Correspondence: Professor H-z Chen, Department of Pharmacology and Biostatistics, Institute of Medical Sciences, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China. E-mail: yaoli@shsmu.edu.cn
2These authors contributed equally to this work.
Received 27 December 2007; Revised 21 August 2008; Accepted 18 September 2008; Published online 5 November 2008.
Abstract
Objectives:
Evidences from randomized clinical trials and meta-analysis have claimed an association between the use of soluble dietary fiber from psyllium and a cholesterol-lowering effect. However, there is still uncertainty as to the dose–response relationship and its long-term lipid-lowering efficacy. This meta-analysis was primarily conducted to address the dose–response relationship between psyllium and serum cholesterol level and time-dependent effect of psyllium in mild-to-moderate hypercholesterolemic subjects.
Methods:
Twenty-one studies, which enrolled a total of 1030 and 687 subjects receiving psyllium or placebo, respectively, were included in the meta-analysis. The studies were randomized placebo-controlled trials, double blinded or open label, on subjects with mild-to-moderate hypercholesterolemia. The dose of psyllium was between 3.0 and 20.4 g per day and intervention period was more than 2 weeks. Any type of diet background was permitted. Diet lead-in period was between 0 and 8 weeks.
Results:
Compared with placebo, consumption of psyllium lowered serum total cholesterol by 0.375 mmol/l (95% CI: 0.257–0.494 mmol/l), and LDL cholesterol by 0.278 mmol/l (95% CI: 0.213–0.312 mmol/l). With random-effect meta-regression, a significant dose–response relationship were found between doses (3–20.4 g/day) and total cholesterol or LDL cholesterol changes. Regression model of total cholesterol was -0.0222+0.2061
log (dose+1), and that of LDL cholesterol was 0.0485+0.1390
log (dose+1). There was a time effect of psyllium on total cholesterol (equation: 6.3640–0.0316
treatment period) and on LDL cholesterol (equation: 4.3134–0.0162
treatment period), suggesting that psyllium reduced serum total cholesterol more quickly than LDL cholesterol.
Conclusions:
Psyllium could produce dose- and time-dependent serum cholesterol-lowering effect in mild and moderate hypercholesterolemic patients and would be useful as an adjunct to dietary therapy for the treatment of hypercholesterolemia.
Keywords:
hypercholesterolemia, total cholesterol, LDL cholesterol, meta-analysis, randomized controlled trials
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Drug Insight: the role of statins in combination with ezetimibe to lower LDL cholesterol
Nature Clinical Practice Cardiovascular Medicine Review (01 Dec 2006)
RESEARCH
European Journal of Clinical Nutrition Original Article
European Journal of Clinical Nutrition Original Article
The effects of psyllium on lipoproteins in type II diabetic patients
European Journal of Clinical Nutrition Scientific Correspondence
European Journal of Clinical Nutrition Original Article
